TABLE 1.
Time (day) | Cumulative amt permeated (μg/cm2) for: |
||
---|---|---|---|
Efinaconazole | Ciclopirox | Amorolfine | |
1 | 0.401 ± 0.672 | NCb | NC |
2 | 0.742 ± 1.242 | NC | NC |
3 | 1.29 ± 1.91 | NC | NC |
4 | 1.59 ± 2.37 | NC | NC |
5 | 2.16 ± 3.11 | NC | NC |
6 | 2.57 ± 3.49 | 0.0998 ± 0.2445 | NC |
7 | 2.94 ± 3.91 | 0.326 ± 0.590 | NC |
8 | 3.45 ± 4.46 | 0.535 ± 0.908 | NC |
9 | 3.98 ± 5.20 | 0.895 ± 1.495 | NC |
10 | 4.49 ± 5.70 | 1.32 ± 2.18 | NC |
11 | 4.84 ± 6.12 | 2.03 ± 3.32 | NC |
12 | 5.42 ± 6.97 | 2.82 ± 4.34 | NC |
13 | 5.90 ± 7.39 | 3.56 ± 5.43 | NC |
14 | 6.53 ± 8.15 | 4.57 ± 6.89 | NC |
Data represent mean ± SD (n = 6).
NC, not calculated because drug concentration in the receptor phase was below the lower limit of quantification (<1 ng/ml) in all samples.